Masarova, L., Reeves, B. N., El Chaer, F., Foltz, L., Tashi, T., Abu-Zeinah, G., … Bose, P. (2025). A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. Front Med (Lausanne), 12, 1548590. https://doi.org/10.3389/fmed.2025.1548590

Masarova, Lucia, Brandi N. Reeves, Firas El Chaer, Lynda Foltz, Tsewang Tashi, Ghaith Abu-Zeinah, Jennifer Lucas, et al. “A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.” Front Med (Lausanne) 12 (2025): 1548590. https://doi.org/10.3389/fmed.2025.1548590.

Masarova L, Reeves BN, El Chaer F, Foltz L, Tashi T, Abu-Zeinah G, et al. A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. Front Med (Lausanne). 2025;12:1548590.

Masarova, Lucia, et al. “A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.” Front Med (Lausanne), vol. 12, 2025, p. 1548590. Pubmed, doi:10.3389/fmed.2025.1548590.

Masarova L, Reeves BN, El Chaer F, Foltz L, Tashi T, Abu-Zeinah G, Lucas J, Halpern AB, Maze D, Qin A, Safah H, Lan F, O’Connell CL, Goel S, Rein L, Fang B, How J, Babu S, Li Z, Cerquozzi S, Oh ST, Hunter AM, Podoltsev N, Vachhani P, Yacoub A, Cunningham JM, Hillis C, Otoukesh S, Zagrijtschuk O, Castro H, Bose P. A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. Front Med (Lausanne). 2025;12:1548590.